Spain's regulator CNMV finds no significant errors in Grifols accounts

Credit: REUTERS/Albert Gea

Adds details

MADRID, March 21 (Reuters) - Beleaguered Spanish drugmaker Grifols will not be required to restate its accounts for the years 2021 and 2022, market supervisor CNMV said on Thursday, as its investigation found no significant errors in the amounts it had reported.

CNMV also found "no evidence that the financial debt reported by Grifols does not correspond to reality," it said.

However, it added that it had identified "deficiencies in the detail and accuracy of breakdowns and explanatory notes in some years".

(Reporting by David Latona and Jesus Aguado; Editing by Andrei Khalip)

((; +34 918 35 68 13;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.